BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 16355329)

  • 21. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
    Zaas AK; Song X; Tucker P; Perl TM
    Clin Infect Dis; 2002 Nov; 35(10):1139-46. PubMed ID: 12410472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes.
    Pelz RK; Lipsett PA; Swoboda SM; Diener-West M; Powe NR; Brower RG; Perl TM; Hammond JM; Hendrix CW
    Intensive Care Med; 2002 Jun; 28(6):692-7. PubMed ID: 12107672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].
    Yiş R; Aslan S; Cıtak C; Değirmenci S
    Mikrobiyol Bul; 2011 Oct; 45(4):646-54. PubMed ID: 22090295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci.
    Sakka V; Tsiodras S; Galani L; Antoniadou A; Souli M; Galani I; Pantelaki M; Siafakas N; Zerva L; Giamarellou H
    Clin Microbiol Infect; 2008 Jan; 14(1):14-21. PubMed ID: 18005178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
    Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
    Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital.
    Calfee DP; Giannetta ET; Durbin LJ; Germanson TP; Farr BM
    Clin Infect Dis; 2003 Aug; 37(3):326-32. PubMed ID: 12884155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients.
    Banach DB; Peaper DR; Fortune BE; Emre S; Dembry LM
    Clin Transplant; 2016 Mar; 30(3):306-11. PubMed ID: 26780305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk factors and clinical outcomes for vancomycin-resistant enterococcus colonization on intensive care unit admission].
    Byun SJ; Kang J
    J Korean Acad Nurs; 2013 Apr; 43(2):287-95. PubMed ID: 23703606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany.
    Wendt C; Krause C; Xander LU; Löffler D; Floss H
    J Hosp Infect; 1999 Jul; 42(3):193-200. PubMed ID: 10439991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections.
    Joels CS; Matthews BD; Sigmon LB; Hasan R; Lohr CE; Kercher KW; Norton J; Sing RF; Heniford BT
    Am Surg; 2003 Jun; 69(6):514-9. PubMed ID: 12852510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in liver transplant recipients.
    Kim YJ; Kim SI; Choi JY; Yoon SK; You YK; Kim DG
    Korean J Intern Med; 2015 Sep; 30(5):694-704. PubMed ID: 26354064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme.
    Grabsch EA; Mahony AA; Cameron DR; Martin RD; Heland M; Davey P; Petty M; Xie S; Grayson ML
    J Hosp Infect; 2012 Dec; 82(4):234-42. PubMed ID: 23103245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia.
    Price CS; Paule S; Noskin GA; Peterson LR
    Clin Infect Dis; 2003 Oct; 37(7):921-8. PubMed ID: 13130403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Emergency of vancomycin-resistant Enterococcus infections in a teaching hospital in Chile].
    Fica A; Jemenao MI; Bilbao P; Ruiz G; Sakurada A; Pérez de Arce E; Zúñiga I; Gompertz M
    Rev Chilena Infectol; 2007 Dec; 24(6):462-71. PubMed ID: 18180821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study.
    Yoon YK; Lee SE; Lee J; Kim HJ; Kim JY; Park DW; Sohn JW; Kim MJ
    J Antimicrob Chemother; 2011 Aug; 66(8):1831-8. PubMed ID: 21652622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissemination of vancomycin-resistant enterococci among haemodialysis patients in Athens, Greece.
    Kalocheretis P; Baimakou E; Zerbala S; Papaparaskevas J; Makriniotou I; Tassios PT; Iatrou C; Kouskouni E; Zerva L
    J Antimicrob Chemother; 2004 Dec; 54(6):1031-4. PubMed ID: 15498878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
    Chavers LS; Moser SA; Funkhouser E; Benjamin WH; Chavers P; Stamm AM; Waites KB
    Microb Drug Resist; 2003; 9 Suppl 1():S69-77. PubMed ID: 14633370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.